Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2858 results

Sort By:

A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy

Study ID: NCT07416162
Start Date: 2026-07-31
End Date: 2029-02-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

21

Intervention / Treatment
Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment

Study ID: NCT06809023
Start Date: 2026-04
End Date: 2029-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Sleep restriction

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

Study ID: NCT07129759
Start Date: 2026-09
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

LUM-201

Sponsor

Lumos Pharma

Source: clinicaltrials.gov

Share:
Add to list

Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

Study ID: NCT07228962
Start Date: 2026-03-31
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

King's College London

Source: clinicaltrials.gov

Share:
Add to list

Immune and Cognitive Benefits of Mango Intake in Young Adults

Study ID: NCT06229262
Start Date: 2026-05
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

Mango group

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan

Study ID: NCT06413160
Start Date: 2026-07-01
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

Jordan Collaborating Cardiology Group

Source: clinicaltrials.gov

Share:
Add to list

Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization

Study ID: NCT07197242
Start Date: 2026-10-01
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

156

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Atomoxetine and Executive Function in PTSD

Study ID: NCT06573970
Start Date: 2026-04-01
End Date: 2029-09-28
Study Type

Interventional

Study Phase

Phase4

No. of Participants

160

Intervention / Treatment

Atomoxetine

Placebo

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Artificial Intelligence for Reconstruction of Echocardiography Studies

Study ID: NCT07093918
Start Date: 2026-04
End Date: 2030-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

V-echo

Litter

Sponsor

The Royal Wolverhampton Hospitals NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma

Study ID: NCT07223294
Start Date: 2026-04
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1430

Intervention / Treatment

Fluticasone furoate and vilanterol inhalation powder

Breo Ellipta

Placebo

Sponsor

Sandoz

Source: clinicaltrials.gov

Share:
Add to list